The role of three interleukin 10 gene polymorphisms (− 1082 A > G, − 819 C > T, − 592 A > C) in the risk of chronic and aggressive periodontitis: a meta-analysis and trial sequential analysis by Wong, Hey Chiann et al.
RESEARCH ARTICLE Open Access
The role of three interleukin 10 gene
polymorphisms (− 1082 A > G, − 819 C > T,
− 592 A > C) in the risk of chronic and
aggressive periodontitis: a meta-analysis
and trial sequential analysis
Hey Chiann Wong1†, Yuxuan Ooi1†, Shaju Jacob Pulikkotil1 and Cho Naing2,3*
Abstract
Background: Periodontitis is a major oral health problem and it is considered as one of the reasons for tooth loss
in developing and developed nations. The objective of the current review was to investigate the association
between IL10 polymorphisms − 1082 A > G (rs1800896), -819C > T (rs1800871), − 592 A > C (rs1800872) and the risk
of either chronic periodontitis or aggressive periodontitis.
Methods: This is a meta- analysis study, following the preferred reporting items for systematic reviews and meta-
analyses (PRISMA). Relevant studies were searched in the health related electronic databases. Methodological
quality of the included studies were assessed using the Newcastle-Ottawa Scale. For individual studies, odds ratio
(OR) and its 95%confidence interval (CI) were calculated to assess the strength of association between IL10
polymorphisms (− 1082 A > G, -819C > T, − 592 A > C) and the risk of periodontitis. For pooling of the estimates
across studies included, the summary OR and its 95% CIs were calculated with random-effects model. The pooled
estimates were done under four genetic models such as the allelic contrast model, the recessive model, the
dominant model and the additive model. Trial sequential analysis (TSA) was done for estimation of the required
information size for this meta-analysis study.
Results: Sixteen studies were identified for this review. The included studies were assessed to be of moderate to good
methodological quality. A significant association between polymorphism of IL10–1082 A > G polymorphism
and the risk of chronic periodontitis in the non-Asian populations was observed only in the recessive model
(OR,1.42; 95% CI:1.11, 1.8,I2: 43%). The significant associations between − 592 A > C polymorphism and the risk
of aggressive periodontitis in the non-Asian populations were observed in particular genetic models such as
allele contrast (OR, 4.34; 95%CI:1.87,10.07,I2: 65%) and recessive models (OR, 2.1; 95% CI:1.16, 3.82,I2: 0%). The
TSA plot revealed that the required information size for evidence of effect was sufficient to draw a
conclusion.
Conclusions: This meta-analysis suggested that the IL10–1082 A > G polymorphism was associated with chronic
periodontitis CP risk in non-Asians. Thus, in order to further establish the associations between IL10 (− 819 C > T, − 592
A > C) in Asian populations, future studies should include larger sample sizes with multi-ethnic groups.
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Background
Periodontitis is defined as an inflammatory disease of
supporting tissues of teeth caused by specific microor-
ganisms or groups of specific microorganisms, resulting
in progressive destruction of the periodontal ligament
and alveolar bone with periodontal pocket formation,
gingival recession or both [1]. There are two forms of
periodontitis such as chronic periodontitis (CP) and ag-
gressive periodontitis (AP). Severe periodontitis can re-
sult in loosening of teeth, leading to occasional pain or
discomfort and impaired mastication and eventual tooth
loss [2]. Periodontitis is a major oral health problem and
it is considered as one of the reasons for tooth loss in
developing and developed nations.
Worldwide, the prevalence of CP in the general adult
population was reported to be 30–35%, with approxi-
mately 10–15% diagnosed with severe CP [3] with geo-
graphic variation. For instance, the estimated prevalence
of CP and severe periodontitis among general population
in Malaysia was 48.5%, and 18.2% respectively [4]. Ac-
cording to the National Health and Nutrition Examin-
ation Survey (NHANES) 2009–2010, the prevalence of
periodontitis and severe periodontitis of adults aged
30 years and above in the United States were 47.2% and
8.5%, respectively [5].
Although the presence of microorganisms is crucial
for the clinical status, host response to bacteria triggers
the secretion of pro-inflammatory mediators, leading to
extra cellular matrix metabolism and bone resorption in
periodontitis [6, 7]. Interleukin (IL)10 is an immunoreg-
ulatory cytokine and down-regulates the Th1 driven
pro-inflammatory response [8]. It is produced mainly by
macrophages apart from numerous other cells such as
Th2 cells, dendritic cells, B-cells, monocytes, neutrophils
eosinophils and mast cells [9]. Studies have shown that
dysregulation of IL10 is associated with an enhanced im-
munopathological response to infection as well as an in-
creased risk for the development of many autoimmune
diseases [10] and infections such as tuberculosis [11]. Al-
though about 99% of human genes are shared across the
same population, variations in sequence and single nu-
cleotide polymorphisms (SNPs) may have significant
predictive relevance. Several IL10 genes implicated to
affect IL10 transcription and secretion include the three
biallelic polymorphisms at position − 1082, − 819 and −
592 [12, 13]. There are molecular epidemiological stud-
ies that assessed the association between IL10 and the
risk of developing periodontitis. These individual studies,
however, showed conflicting results. Such inconsistency
of the results may be attributed to small sample size, in-
sufficient statistical power and ethnic diversity of the
population. Taken together, the objective of the current
review was to investigate the association between poly-
morphisms of IL10–1082 A > G (rs1800896), -819C > T
(rs1800871), − 592 A > C(rs1800872) and the risk of ei-
ther CP or AP.
Methods
The current study followed the preferred reporting items
for systematic reviews and meta- analyses (PRISMA)
[14] (Additional file 1).
Study search
Relevant studies were searched in the health-related
electronic databases of PubMed, EMBASE, web of sci-
ence and google scholar, with the combination of the
keywords with Boolean operators: “periodontitis” OR
“chronic periodontitis” OR “aggressive periodontitis”
AND “interleukin-10” OR “IL10” OR “-1082 A/G”. OR
“-819 C > T” OR “-592 A > C”.
The search was limited to the studies published in
English and Chinese (abstract in English) from 1968
until March 2018. The references of retrieved articles
and relevant reviews were checked for any additional
studies.
Inclusion criteria
Human studies of any sample size that assessed peri-
odontitis were included, if:
i) IL10–1082 A > G (rs1800896), 592 A > C
(rs1800872) and/or − 819 C > T (rs1800871) were
investigated.
ii) it was case-control or nested case-control design.
iii) periodontally healthy controls were included.
iv) genotype distribution in both cases and controls
were available.
CP and AP in the current analysis were as defined in
the primary studies. Studies, which did not meet the in-
clusion criteria were excluded. Studies based on family
or sibling-pairs were also excluded.
Data extraction
Three investigators (HCW, YO, CN) individually checked
the titles and abstracts, and then selected the relevant
full-text articles, according to the inclusion criteria. The
three investigators independently extracted data, using a
piloted data extraction form. The following information
were collected from each study: author, publication year,
country, design (e.g. hospital-based study, population-based
study), the number of cases and controls, the racial descent
(Asian or non-Asian), clinical types of periodontitis, geno-
typing method and genotype/allele distribution in both
cases and controls. Any discrepancy was resolved by discus-
sion and consensus. If allele frequency was zero, then a
value of 1 was added to all allele, following Laplace approxi-
mation [15].
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Methodological quality assessment
The two investigators (HCW, YO) independently assessed the
methodological quality of studies, using the Newcastle-Ottawa
Scale (NOS) for quality assessment [16], with necessary
modifications. The scores were based on three main as-
pects: the selection of the study groups (maximum 4
points: whether the case definition was adequate with
independent validation; whether the patients were con-
secutive or obviously representative series of cases;
whether the controls were population-based; whether
the controls were persons without history of periodon-
titis); the comparability of the groups (maximum 2
points: whether cases and controls were matched for
age and gender; whether cases and controls were
matched for region or ethnicity); and the ascertainment
of exposure (maximum 3 points: whether the ascertain-
ment of exposure was secure record; whether the same
method of ascertainment was applied for cases and
controls; whether the same non-response rate was re-
ported for both groups). A total score for each study
can vary from 0 (worst) to 9 (best). Studies scoring ≤4
were regarded as low quality, while a score of ≥7 was
considered as a high-quality study. Any discrepancy be-
tween the two investigators was resolved by discussion
and consensus.
Statistical analysis
Hardy-Weinberg Equilibrium (HWE) in the controls
was tested, using the exact test for goodness-of-fit and
p > 0.05 was regarded as consistent with HWE [17]. The
strength of the association between IL10 (− 1082 A >
G,-819 C > T, − 592 A/C) and the risk of periodontitis
(CP or AP) was estimated using odds ratio (OR) and its
95% confidence interval (CIs). Heterogeneity was statisti-
cally assessed using the I2 test. The I2 test values de-
scribes the percentage of total variation across studies
that is attributable to the heterogeneity rather than
chance. I2 values greater than 50% is considered as sub-
stantial heterogeneity [18]. For pooling of the estimates
across studies included, the summary ORs and corre-
sponding 95% CIs were calculated with random-effects
model (The Der Simonian and Laird method) in the
presence of between–study heterogeneity of the studies.
Otherwise, fixed-effect model (the Mental-Haenszel
method) was used. We estimated the pooled ORs and its
95% CIs in four genetic models: − 592 A > C the allelic
contrast model (A vs C), the recessive model (AA vs CA
+ CC), the dominant model (AA+CA vs CC) and the
additive model (AA vs CC). As for − 1082 A > G the al-
lelic contrast model (A vs G), the recessive model (AA
vs GA + GG), the dominant model (AA+GA vs GG) and
the additive model (AA vs GG). As for − 819 C > T the
allelic contrast model (T vs C), the recessive model (TT
vs CT + CC), the dominant model (TT + CT vs CC) and
the additive model (TT vs CC) was used. Analysis was
further stratified by the clinical forms of periodontitis
(CP, AP) and by ethnic decent. To assess the stability of
results, the sensitivity analysis was done with
leave-one-out meta-analysis by sequential omission of
individual studies [19]. We assessed the publication bias
by visualizing funnel plots [20, 21].
Trial sequential analysis (TSA), an approach that ad-
just for random error risk, was done for estimation of
the required information size [22]. It is classified as ‘po-
tentially spurious evidence of effect’, if the cumulative
Z-curve did not cross the monitoring boundaries or as
‘firm evidence of effect’, if the cumulative Z-curve
crossed the monitoring boundaries [23].
Meta-analysis was done with RevMan 5.3 (The
Cochrane collaboration, Copenhagen) and Leave-one-out
meta-analysis was with meta package (metabin command)
in R 3.4.3 software (The R Foundation). TSA was done
with TSA version 0.9 beta (Copenhagen Trial Unit, Centre
for Clinical Intervention Research, Copenhagen).
Results
Figure 1 provides a four-phase study selection process in
the present meta-analysis study. A total of 132 studies
were identified in the initial search. After the title and ab-
stract screening, 29 full- text articles were retrieved. Of
these, a final of 16 articles (with 1557 cases and 1447 con-
trols) were identified for this review [24–39]. All except
one study were published in English language. One study
was published in Chinese language, but provided English
language abstract [27]. The studies included used different
criteria for diagnosis of periodontitis such as clinical cri-
teria (44%,7 studies), 1999 classification of periodontal dis-
eases and conditions (25%,4 studies), clinical criteria and
X-ray verification (19%, 3 studies) and criteria of the
American Academy of Periodontology (13%, 2 studies).
The main characteristics of the studies identified for
this review are presented in Additional file 2.
Summary of the 13 excluded studies [12, 40–51] are
provided in Additional file 3. These 16 studies in-
cluded were conducted in nine countries such as
eight single studies from China [27], Germany [29],
Macedonia [33], Norway [36], Peru [34], Taiwan [30],
Turkey [31] and the United Kingdom [25], three stud-
ies from Iran [26, 33, 39] and six studies from Brazil
[24, 28, 30, 35, 37, 38]. Of these sixteen, six studies
assessed all three candidate SNPs [24, 30, 32, 36–38]
in the risk of CP/AP, while thirteen and nine studies
assessed − 1082 A > G, and − 819 C > T or − 592 A > C,
respectively. All these studies recruited healthy con-
trols. All, except two studies [32, 34] were consistent
with HWE. All these 16 studies were with moderate
to good methodological quality, based on the NOS
criteria (Additional file 4).
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Quantitative estimates
Overall, there was statistical significant associations be-
tween IL10–1082 A > G polymorphism and the risk of
AP in a subgroup of the non-Asian population under
the recessive model (OR,1.42;95% CI,1.11–1.8,I2:43%)
(Fig. 2). For IL10–592 A > C, only the non-Asian popula-
tions under the allele contrast model (C vs A) (OR,4.34;
95%CI:1.87–10.07, I2:65%) and the recessive model
(OR,2.1;95% CI,1.16–3.82,I2:0%) showed significant rela-
tionship between this SNP and the risk of AP (Fig. 3).
For IL10–819C > T, there was no significant associations
between this SNP and the risk of CP/AP in any popula-
tion groups under any of four genetic models (Fig. 4).
Summary of the evaluation of the three candidate SNPs
stratified by population groups and clinical types under
four genetic models are provided in Additional file 5.
Sensitivity analysis
To assess the influence of individual data on the pooled
ORs, leave-one-out meta-analysis was performed. The
overall estimate of recessive model of IL10–1082 A >G
remained statistical significance, while omitting any single
study (Fig. 5). This indicates that the results are stable.
This was true for all other models with the 3 candidate
SNPs. As an example, a subgroup analysis stratified by
diagnostic criteria was done on CP patients with − 1082
A >G under recessive model: CP patients diagnosed only
by clinical criteria was significantly associated with this
SNP (Additional file 6). This implied that the diagnostic
criteria for CP had impact on the direction of association.
Begg’s and Egger’s test showed no evidence of publication
bias in all analyses concerning IL10 (− 1082 A >G, − 819
C > T, 592C > A) polymorphisms. An example illustration
Fig. 1 Flow chart of the study selection process




Fig. 2 Forest plot of − 1082 A > G. a Allele genetic model, b





Fig. 3 Forest plot of − 592 A > C. a Allele genetic model, b
Recessive model, c Dominant model, d additive model




Fig. 4 Forest plot of − 819 C > T. a Allele genetic model, b Recessive model, c Dominant model, d additive model
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with IL10–1082 A >G under dominant model is shown in
Additional file 7.
TSA
We performed TSA with studies on IL10–1082 A>G in CP
that followed HWE. We used an overall 5% risk of a type I
error and 20% risk of a type II error (power of 80%). The cu-
mulative z-curve crossed the traditional boundary and the
trial sequential monitoring boundary and reached the re-
quired information size, suggesting there is no need for more
evidence to establish additional study of − 1082 A>G in CP
among the non-Asian population (Additional file 8).
Discussion
The current study provides evidence on the association
between IL10 (− 1082 A > G, − 819 C > T, − 592 A > C)
and the risk of CP/AP, and the major observations are as
follows;
i. A significant association between − 1082 A > G
polymorphism and the risk of CP in the non-Asian
populations was observed only in the recessive
model.
ii. In subgroups with ethnicity, the significant
associations between − 592 C > A polymorphism
and the risk of AP in the non-Asian populations
were observed in particular genetic models such as
allele contrast and recessive models.
iii. The TSA plot revealed that the required
information size for evidence of effect was sufficient
to draw a firm conclusion.
The numbers of inflammatory leucocytes that express
the anti-inflammatory IL10- cytokine are much more
widely distributed than those that express the
pro-inflammatory IL6- cytokine and TNF-a- cytokine
[52]. The pooled analysis of 11 studies in this review
showed a significant association between -1082A > G
and the risk of CP in the non-Asian population under
recessive model and this estimate was stable even with
sensitivity analysis. Therefore, the findings suggest a pos-
sible role of racial difference in genetic backgrounds.
Genotypic differences in cytokine genes are differently
inherited to ethnically different populations [24]. The
lack of statistical significance in the remaining genetic
models might partly be due to the relatively small sam-
ple size. This was indirectly supported by an earlier re-
view on this SNP, which included eight studies on
patients with CP had reported no significance associ-
ation with -1082A > G under any of four genetic models
[53]. Another meta-analysis in this field, which included
nine case-control studies had also reported no signifi-
cance association with -1082A > G under any genetic
models [54]. In subsequent analysis of patients with AP,
no significant association was found with this SNP and
this also might partly be related to limited size of sam-
ples as relatively few number of studies were assessed
for this clinical form.
A significant association between − 592 A > C poly-
morphism and the risk of AP in allele contrast and reces-
sive model indicated the prominent role of AA in the risk
development. Although environmental factors are consid-
ered to be important in the establishment of periodontitis,
individuals reared or living in similar environments may
manifest significantly different disease patterns [55]. The
pooled results showed no significant association between
− 819 C > T and the risk of CP/AP in the non-Asian popu-
lation under all four genetic models could also be related
to ethnical homogeneity of the studied populations [34],
the limited size of samples or different in selection criteria
of patients/controls. The − 819 C > T SNP lies within a
DNA motif forming a putative oestrogen responsive
Fig. 5 Leave-one out analysis on − 1082 A > G Allele genetic model
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element [56]. Hence, the dominant proportion of females
or males in the primary studies was likely to affect the lack
of associations in this review.
The reason why different association was observed in
different SNPs remained unclear. One possible explan-
ation is the differences in the frequencies of the poly-
morphisms among diverse ethnicity, which may partly
give rise to heterogeneity. Moreover, the complex nature
of the disease, which is the result of an interplay be-
tween immunological, microbiological and environmen-
tal factors, may be the reason for that no difference [40].
Smoking habit represents an additional factor involved
in periodontal disease progression that could mask the
effects of IL10 SNPs on periodontitis outcome [44].
Additionally, gene-gene interactions along with environ-
mental factors could also contribute to the complexity
of genetic effect. Hence, variation in single genetic locus
is often insufficient to predict risk of disease. For in-
stance, there might be some extent of interaction with
IL10 (− 1082 A > G, − 819 C > T, 592 C > A) and other
genes (gen-gen interaction/synergism).
It is postulated that polymorphisms in genes that co-
dify mediators involved in the upstream positions of
inflammatory-immune response pathways (such as IL-10
cytokine), which modulate a broad range of factors, may
be relevant to periodontitis outcome [28, 57].
Genotypic differences in cytokine genes are differently
inherited to ethnically different populations [24]. Individ-
uals who are high producers of IL-10 cytokine might be
more protected against CP due to its anti-inflammatory
role. Therefore, a genetically determined increase of
anti-inflammatory IL-10 cytokine would down regulate
the immune response against periodontopathogenic bac-
teria [41, 51].
On the other side, polymorphisms in downstream genes
(such as metalloproteinase and osteoclastogenesis), whose
products present a narrow action in the pathways involved
in periodontal tissue destruction, would play a minor role
(or even do not play a significant role) in the development
of periodontal diseases [28]. For the development of AP,
low interleukin-10 levels lead to an enhanced release of
pro-inflammatory cytokines, such as tumor necrosis
factor-alpha, which have been implicated in alveolar bone
loss [29, 58].
Study limitations
There are some limitations in the present study. Only two
studies included in this meta-analysis (11.7%) were from
the Asia population. A small sample size in the Asian
population subgroup analyses may not be the representa-
tive of the population. Hence, a selection bias with geo-
graphical imbalance is a concern. Our analysis was done
with the unadjusted raw data provided in the primary stud-
ies, in which patients might have some common factors
(i.e. age, gender, diets, smoking habits, diabetes). An earlier
meta-analysis had highlighted that the inclusion of both
smoking and non-smoking subjects in the primary studies
can be an additional source of variability [54]. Stratified
analysis by age group, smoking habits, oral hygiene habits
or presence of comorbidity were not possible due to lim-
ited data. Hence, the findings could be confounded with
these common factors. A stratification analysis on − 1082
A >G in the CP patients documented that the estimates
could vary with the type of diagnosis criteria. If cases and
controls have been genotyped in separate batches in the
primary studies, differential misclassification of exposure is
a concern. The sample sizes in most of the included studies
were relatively small and were under power to detect sta-
tistically significant differences between the cases and con-
trols. Meta-analysis, however, is a retrospective synthesis of
published studies and power analysis is not applicable and
type II errors are expected to be less common in a
meta-analysis than in single studies [18, 19]. The manifest-
ation of many systemic diseases which may lead to com-
promised host function should also be considered. For
example, diabetes and rheumatoid arthritis are examples of
diseases which may have a genetic component and may
have enhanced periodontal breakdown as a secondary fea-
ture. In the presence of publication bias in this analysis,
non-published studies and/or studies in other language
might have been missed in the current review. Moreover,
there might be some extent of interaction with IL10 (−
1082 A >G, − 819 C >T, IL10 592 A >C) and other genes
(gen-gen interaction/synergism). Hence, findings in the
current meta-analysis should be interpreted with caution.
Implications
Interventions with the manipulation of anti-inflammatory
cytokines have been suggested as adjuvants for treating
periodontal disease. The efficacy of anti-cytokine biothera-
pies in patients with inflammatory diseases is a proof that
blocking the effects of a cytokine can slow down the dis-
ease process [59]. Investigating the association of the IL10
gene polymorphisms with periodontitis susceptibility may
promote our understanding of its pathogenesis and ex-
plain individual differences in the risk.
Conclusions
Findings suggest that the IL10–1082 A>G polymorphism
was associated with CP risk in non- Asians. To further estab-
lish the associations between IL10 (819 C>T, 592 A >C), fu-
ture studies with larger sample sizes and multi-ethnic sample
groups more with Asian population are required.
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